Korean companies set to launch high-dose Gleevec pills
Dasan has worked together with the country's seven leading pharmaceutical companies to develop Gleevec (imatinib) 400 mg. To this end, the company completed Ph...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
